Humoral and Cell‐Mediated Immune Responses to an Early 2‐Dose Measles Vaccination Regimen in the United States

Abstract

Background. Shifts in peak measles incidence to children<12 months old and the associated high mortality support the study of an early 2-dose measles vaccine regimen.